Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron and Dexamethasone for PONV
NCT06886230Phase 4Completed
- Start
- Mar 2025
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of ondansetron and dexamethasone in postoperative nausea and vomiting (PONV) (4 arms). Primary endpoint: Incidence of Postoperative Nausea and Vomiting at 24 hours. Started Mar 2025; status: completed.
02
Drugs
ondansetrondexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06886230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06886230.